Close

Lion Biotechnologies (LBIO) Names New CFO

Go back to Lion Biotechnologies (LBIO) Names New CFO

Lion Biotechnologies Appoints Gregory Schiffman as Chief Financial Officer

October 3, 2016 8:00 AM EDT

NEW YORK, NY -- (Marketwired) -- 10/03/16 -- Lion Biotechnologies, Inc. (NASDAQ: LBIO), a biotechnology company developing novel cancer immunotherapies based on tumor-infiltrating lymphocytes (TILs), today announced the appointment of Gregory T. Schiffman, MBA as Chief Financial Officer of the company, effective immediately.

"As we continue to build the management team into a fully integrated oncology organization, we are delighted to welcome Greg to the team," said Lion Biotechnologies President and CEO, Maria Fardis, Ph.D. "Greg has extensive experience in the cell-based therapy space having overseen finance, accounting and manufacturing functions in his... More